- Home
- News
News about CCII and Cancer Immunotherapy
Find out what is happening at CCII and in the field of cancer immunotherapy. Here we share the latest news about research at CCII and the CCII research community and about trends in immunology and cancer research.
Featured News
Spermidine to the Rescue?
Spermidine, a polyamine compound found in ribosomes and living tissues and originally isolated from semen, is an increasingly popular anti-aging supplement. Muna Al-Habsi and her colleagues demonstrate in a new paper published in Science that spermidine can enhance cancer immunotherapy blocking the PD-1 pathway by reversing aging effects in killer T-cells.
All News
-
The Multipurpose Hall is now available for use!
We invite you to use our wonderful hall with 176 seats for your events.
More
-
CCII Introduction Video Now Live!
We invite you to watch and explore the story behind CCII!
More
-
Highlights of the CCII Opening Ceremony and 1st International Symposium
Newly published highlights of the Opening Ceremony and 1st International Symposium
More
-
[CLOSED] Call for Applications for CCII’s 2025 Doctoral Program Scholarships
The Call for Applications for CCII's 2025 Doctoral Program Scholarships is closed. Application deadline was January 31st, 2025.
More
-
Opening Ceremony for CCII’s new home, the Bristol Myers Squibb Building
On 12th November 2024, the Opening Ceremony for the newly constructed Bristol Myers Squibb Building, which will serve as the hub for activities of the CCII, will be held.
More